Novel Sulfated Polysaccharides Disrupt Cathelicidins, Inhibit RAGE and Reduce Cutaneous Inflammation in a Mouse Model of Rosacea
2011

Sulfated Polysaccharides for Treating Rosacea

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Zhang Jianxing, Xu Xiaoyu, Rao Narayanam V., Argyle Brian, McCoard Lindsi, Rusho William J., Kennedy Thomas P., Prestwich Glenn D., Krueger Gerald

Primary Institution: University of Utah

Hypothesis

A topically-applied SAGE could be used as a novel therapy for rosacea by binding and inhibiting the inflammatory activity of excess cationic cathelicidins.

Conclusion

SAGEs offer potential as novel mechanism-based therapies for rosacea and other skin diseases driven by LL-37 and RAGE interactions.

Supporting Evidence

  • SAGEs were anti-inflammatory at ng/ml concentrations.
  • SAGEs inhibited interleukin-8 production induced by LL-37.
  • Topical application of SAGEs reduced erythema and PMN infiltration.
  • SAGEs bound LL-37 and inhibited its biological activity.

Takeaway

This study found that a new type of sugar molecule can help reduce redness and inflammation in skin conditions like rosacea.

Methodology

The study tested semi-synthetic glycosaminoglycan ethers (SAGEs) on inflammation pathways in a mouse model of rosacea.

Participant Demographics

Primarily Caucasian women of Celtic descent.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016658

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication